Yamashita Health Care Holdings,Inc. (9265.T)
JPY 2805.0
(0.0%)
JPY 2805.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 580 Million JPY | 164.84% |
| 2022 | 219 Million JPY | -68.53% |
| 2021 | 696 Million JPY | 2.58% |
| 2020 | 678.49 Million JPY | 47.59% |
| 2019 | 459.7 Million JPY | 218.3% |
| 2018 | 144.42 Million JPY | -34.53% |
| 2017 | 220.6 Million JPY | 1036.69% |
| 2016 | 19.4 Million JPY | -94.16% |
| 2015 | 332.23 Million JPY | -7.45% |
| 2014 | 359 Million JPY | -35.08% |
| 2013 | 553 Million JPY | 72.27% |
| 2012 | 321 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 83 Million JPY | -39.86% |
| 2023 Q4 | 138 Million JPY | 463.16% |
| 2023 FY | 580 Million JPY | 164.84% |
| 2023 Q3 | -38 Million JPY | -111.95% |
| 2023 Q2 | 318 Million JPY | 96.3% |
| 2023 Q1 | 162 Million JPY | -25.69% |
| 2022 FY | 219 Million JPY | -68.53% |
| 2022 Q3 | 202 Million JPY | 155.19% |
| 2022 Q2 | -366 Million JPY | -321.82% |
| 2022 Q4 | 218 Million JPY | 7.92% |
| 2022 Q1 | 165 Million JPY | 59.03% |
| 2021 Q4 | 103.75 Million JPY | -13.92% |
| 2021 Q1 | 144.29 Million JPY | -20.59% |
| 2021 Q2 | 327.51 Million JPY | 126.98% |
| 2021 Q3 | 120.52 Million JPY | -63.2% |
| 2021 FY | 696 Million JPY | 2.58% |
| 2020 Q4 | 181.71 Million JPY | -3.44% |
| 2020 Q1 | 50.76 Million JPY | -17.01% |
| 2020 Q2 | 257.82 Million JPY | 407.91% |
| 2020 Q3 | 188.19 Million JPY | -27.01% |
| 2020 FY | 678.49 Million JPY | 47.59% |
| 2019 FY | 459.7 Million JPY | 218.3% |
| 2019 Q2 | 327.36 Million JPY | 278.82% |
| 2019 Q3 | -15.24 Million JPY | -104.66% |
| 2019 Q4 | 61.16 Million JPY | 501.13% |
| 2019 Q1 | 86.41 Million JPY | 6028.94% |
| 2018 Q4 | 1.41 Million JPY | -97.48% |
| 2018 Q3 | 56 Million JPY | -62.68% |
| 2018 Q2 | 150.06 Million JPY | 337.98% |
| 2018 FY | 144.42 Million JPY | -34.53% |
| 2018 Q1 | -63.05 Million JPY | -122.68% |
| 2017 Q3 | -76 Million JPY | -173.08% |
| 2017 Q1 | -85 Million JPY | -153.13% |
| 2017 FY | 220.6 Million JPY | 1036.69% |
| 2017 Q4 | 278.02 Million JPY | 465.82% |
| 2017 Q2 | 104 Million JPY | 222.35% |
| 2016 FY | 19.4 Million JPY | -94.16% |
| 2016 Q4 | 160 Million JPY | 207.38% |
| 2016 Q2 | 38 Million JPY | 226.67% |
| 2016 Q1 | -30 Million JPY | -119.48% |
| 2016 Q3 | -149 Million JPY | -492.11% |
| 2015 Q4 | 154 Million JPY | 250.0% |
| 2015 Q1 | - JPY | -100.0% |
| 2015 FY | 332.23 Million JPY | -7.45% |
| 2015 Q2 | 134 Million JPY | 0.0% |
| 2015 Q3 | 44 Million JPY | -67.16% |
| 2014 Q3 | 35 Million JPY | -75.69% |
| 2014 Q2 | 144 Million JPY | 900.0% |
| 2014 Q1 | -18 Million JPY | -109.33% |
| 2014 FY | 359 Million JPY | -35.08% |
| 2014 Q4 | 198 Million JPY | 465.71% |
| 2013 Q3 | 78 Million JPY | -58.73% |
| 2013 Q4 | 193 Million JPY | 147.44% |
| 2013 FY | 553 Million JPY | 72.27% |
| 2013 Q1 | 93 Million JPY | -23.77% |
| 2013 Q2 | 189 Million JPY | 103.23% |
| 2012 Q2 | 121 Million JPY | 0.0% |
| 2012 FY | 321 Million JPY | 0.0% |
| 2012 Q3 | 13 Million JPY | -89.26% |
| 2012 Q4 | 122 Million JPY | 838.46% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| OLBA HEALTHCARE HOLDINGS, Inc. | 1.5 Billion JPY | 61.343% |
| Alfresa Holdings Corporation | 29.55 Billion JPY | 98.038% |
| Vital KSK Holdings, Inc. | 5.84 Billion JPY | 90.074% |
| WIN-Partners Co., Ltd. | 1.83 Billion JPY | 68.405% |
| MediPal Holdings Corporation | 41.47 Billion JPY | 98.602% |
| AS ONE Corporation | 7.5 Billion JPY | 92.267% |
| Suzuken Co., Ltd. | 29.01 Billion JPY | 98.001% |